<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-47-1757C135">
 <label>135</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Benbrik</surname>
    <given-names>E.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chariot</surname>
    <given-names>P.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bonavaud</surname>
    <given-names>S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ammi-Saı¨d</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Frisdal</surname>
    <given-names>E.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rey</surname>
    <given-names>C.</given-names>
   </name>
   <etal>et al.</etal>
  </person-group> (
  <year>1997</year>) 
  <article-title>Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells</article-title>. 
  <source>J. Neurol. Sci.</source>
  <volume>149</volume>, 
  <fpage>19</fpage>–
  <lpage>25</lpage>
  <pub-id pub-id-type="doi">10.1016/S0022-510X(97)05376-8</pub-id>
  <pub-id pub-id-type="pmid">9168161</pub-id>
 </mixed-citation>
</ref>
